gptkbp:instanceOf
|
local anesthetic
|
gptkbp:ATCCode
|
N01BB04
|
gptkbp:brand
|
Citanest
EMLA (with lidocaine)
|
gptkbp:CASNumber
|
721-50-6
|
gptkbp:category
|
local anesthetics
secondary amines
anilides
|
gptkbp:chemicalFormula
|
C13H20N2O
|
gptkbp:combines
|
gptkb:lidocaine
|
gptkbp:contraindication
|
congenital or idiopathic methemoglobinemia
|
gptkbp:discoveredBy
|
Claes Tegner
|
gptkbp:discoveredIn
|
1953
|
gptkbp:eliminationHalfLife
|
1.5–2 hours
|
gptkbp:excretion
|
renal
|
https://www.w3.org/2000/01/rdf-schema#label
|
prilocaine
|
gptkbp:IUPACName
|
N-(2-methylphenyl)-2-(propylamino)propanamide
|
gptkbp:KEGGID
|
D08413
|
gptkbp:legalStatus
|
prescription only
|
gptkbp:meltingPoint
|
37–38 °C
|
gptkbp:MeSH_ID
|
D011322
|
gptkbp:metabolism
|
liver
|
gptkbp:molecularWeight
|
220.31 g/mol
|
gptkbp:pregnancyCategory
|
B (US)
|
gptkbp:PubChem_CID
|
4738
CHEMBL1201212
4906
|
gptkbp:riskFactor
|
gptkb:methemoglobinemia
|
gptkbp:routeOfAdministration
|
injection
topical
|
gptkbp:sideEffect
|
cyanosis
dizziness
numbness
tingling
|
gptkbp:UNII
|
98PI200987
|
gptkbp:usedFor
|
local anesthesia
|
gptkbp:bfsParent
|
gptkb:Bier_block
gptkb:Lidocaine
gptkb:A&P_Cream
|
gptkbp:bfsLayer
|
8
|